Viewing Study NCT04941066


Ignite Creation Date: 2025-12-24 @ 4:26 PM
Ignite Modification Date: 2025-12-26 @ 1:30 PM
Study NCT ID: NCT04941066
Status: COMPLETED
Last Update Posted: 2023-01-18
First Post: 2021-06-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Cognitive Process-based Real-time fMRI Neurofeedback in MDD and Rumination
Sponsor: Laureate Institute for Brain Research, Inc.
Organization:

Study Overview

Official Title: Cognitive Process-based Real-time fMRI Neurofeedback in MDD and Rumination
Status: COMPLETED
Status Verified Date: 2023-01
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: CNF-rumination
Brief Summary: The purpose of this study is to assess the feasibility and efficacy of real-time fMRI neurofeedback for rumination.
Detailed Description: Neuroimaging MRI techniques for measuring brain structure, tissue composition, and Blood Oxygenation Level Dependent functional Magnetic Resonance imaging (BOLD fMRI) will be used to measure task-dependent and task-independent brain hemodynamic and electrophysiological changes in human subjects with major depressive disorders (MDD).

After being informed about the study and potential risks, all participants giving written informed consent will undergo one session of the cognitive process-based fMRI neurofeedback (CNF) targeting the rumination-related brain functional connectivity, and a one-week follow-up. Participants will be randomized in a double-blind manner (participant and investigator) in a 1:1 ratio to Active (receiving feedback from their own brain activity) or Sham (receiving artificially generated feedback).

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: